UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark One)

|X|   QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES  EXCHANGE ACT
      OF 1934

                                For the quarterly period ended March 31, 2005

|_|   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

                                For the transition period from_____ to ______

                         Commission File No. 333-105840

                         MEDICAL MEDIA TELEVISION, INC.
        (Exact Name of Small Business Issuer as Specified in Its Charter)

<TABLE>
<CAPTION>
<S>                                                                    <C>
                  Florida                                                           59-3459320
                  -------                                                           ----------
(State or Other Jurisdiction of Incorporation or Organization)          (I.R.S. Employer Identification No.)
</TABLE>

                           8406 Benjamin Road, Suite C
                              Tampa, Florida 33634
                              --------------------
                    (Address of Principal Executive Offices)

                                 (813) 888-7330
                                 --------------
                           (Issuer's Telephone Number)

                        PetCARE Television Network, Inc.
--------------------------------------------------------------------------------
              (Former Name, Former Address and Former Fiscal Year,
                         if Changed Since Last Report)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. Yes [ ] No [X]

As of May 10, 2005,  1,309,476  shares of the Issuer's  common stock,  par value
$.0005, were outstanding.

Transitional Small Business Disclosure Format (check one): Yes [ ] No [X]

================================================================================
<PAGE>

                                        2
PART I - FINANCIAL INFORMATION

Item 1.     Financial Statements.

      In  the  opinion  of  management,  the  accompanying  unaudited  financial
statements included in this Form 10-QSB reflect all adjustments (consisting only
of normal recurring  accruals)  necessary for a fair presentation of the results
of  operations  for the periods  presented.  The results of  operations  for the
periods  presented are not necessarily  indicative of the results to be expected
for the full year.

<TABLE>
<CAPTION>
<S>                                                                                  <C>
Accountants' Review Report                                                               3

Balance Sheets as of March 31, 2005 and December 31, 2004                                4

Statements of Operations for the three months ended March 31, 2005 and 2004,
and from inception (October 2, 1989) through March 31, 2005                              5

Statements of Changes in Stockholders' Equity from inception (October 2, 1989)
through March 31, 2005                                                                   6

Statements of Cash Flows for the three months ended March 31, 2005 and 2004,
and from inception (October 2, 1989) through March 31, 2005                              7

Notes to the Financial Statements                                                     8-16
</TABLE>


                                       2
<PAGE>

                         BAUMANN, RAYMONDO & COMPANY PA
                         405 North Reo Street, Suite 405
                              Tampa, Florida 33609
                                  (813)288-8826

                           ACCOUNTANTS' REVIEW REPORT

Board of Directors
Medical Media Television, Inc.
f/k/a PetCARE Television Network, Inc.

We have reviewed the  accompanying  balance sheets of Medical Media  Television,
Inc.  f/k/a  PetCARE  Television  Network,  Inc. as of March 31,  2005,  and the
related statements of operations,  stockholders'  equity, and cash flows for the
period then ended in accordance  with Statements on Standards for Accounting and
Review   Services  issued  by  the  American   Institute  of  Certified   Public
Accountants.  All  information  included in these  financial  statements  is the
representation of the management of Medical Media Television, Inc. f/k/a PetCARE
Television Network, Inc.

A review consists  principally of inquiries of company  personnel and analytical
procedures  applied to financial data. It is substantially less in scope than an
audit in accordance with generally accepted auditing standards, the objective of
which is the expression of an opinion  regarding the financial  statements taken
as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should
be made to the  accompanying  financial  statements  in order  for them to be in
conformity with generally accepted accounting principles.

As discussed in Note A, the Company has been in the development  stage since its
inception on October 2, 1989.  Realization  of a major  portion of the assets is
dependent upon the Company's ability to meet its future financing  requirements,
and the success of future  operations.  These  factors raise  substantial  doubt
about the Company's ability to continue as a going concern.

/s/ BAUMANN, RAYMONDO & COMPANY PA
May 12, 2005


                                       3
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                     f/k/a/ PetCARE Television Network, Inc.
                          (A DEVELOPMENT STAGE COMPANY)
                                  BALANCE SHEET

<TABLE>
<CAPTION>
                                                                            March 31,       December 31,
                                                                              2005             2004
                                       ASSETS                               Unaudited         Audited
                                                                           -----------      -----------
<S>                                                                        <C>              <C>
Current assets:
    Cash                                                                   $    57,501      $    18,793
    Accounts receivable, net of reserves                                           300            9,470
    Prepaid expenses                                                            49,349           77,374
    Other receivables                                                           20,500              871
                                                                           -----------      -----------
         Total current assets                                                  127,650          106,508
                                                                           -----------      -----------

Fixed assets:
    Computer equipment                                                          10,265           10,265
    Leasehold imporvements                                                       6,196            6,196
    Accumulated depreciation                                                    (6,151)          (4,924)
                                                                           -----------      -----------
                                                                                10,310           11,537
                                                                           -----------      -----------

Other assets:
    Security deposits                                                            7,596            7,596
                                                                           -----------      -----------

         Total assets                                                      $   145,556      $   125,641
                                                                           ===========      ===========

                      LIABILITIES AND STOCKHOLDERS' DEFICIT

Current liabilities:
    Accounts payable                                                       $    97,727      $    57,851
    Accrued expenses and other current liabilities                             569,387          376,992
    Deferred revenue                                                            15,851           12,068
    Notes payable to stockholders                                            2,377,500        2,127,500
                                                                           -----------      -----------
         Total current liabilities                                           3,060,465        2,574,411
                                                                           -----------      -----------

Long-term liabilities
    Notes payable                                                            1,375,000        1,375,000
    Note payable to stockholder                                                 50,000           50,000
    Deferred revenue                                                            20,781           20,004
                                                                           -----------      -----------
         Total long-term liabilities                                         1,445,781        1,445,004
                                                                           -----------      -----------

         Total liabilities                                                   4,506,246        4,019,415
                                                                           -----------      -----------

    Stockholders' deficit:
       Preferred stock - no par value; 25,000,000 shares  authorized;
       Common stock - par value $.0005; 100,000,000 shares authorized;
        13,091,685 shares issued and outstanding                                 6,546            6,546
       Additional paid-in capital                                              671,668          671,668
       Accumulated deficit during development stage                         (5,038,904)      (4,571,988)
                                                                           -----------      -----------
          Total stockholders' deficit                                       (4,360,690)      (3,893,774)
                                                                           -----------      -----------

          Total liabilities and stockholders' deficit                      $   145,556      $   125,641
                                                                           ===========      ===========
</TABLE>

                       See Notes to Financial Statements.


                                       4
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                     f/k/a PetCARE Television Network, Inc.
                          (A DEVELOPMENT STAGE COMPANY)
                       UNAUDITED STATEMENTS OF OPERATIONS
               FOR THE THREE MONTHS ENDED MARCH 31, 2005 AND 2004
               FROM INCEPTION (OCTOBER 2, 1989) to MARCH 31, 2005

<TABLE>
<CAPTION>
                                                                                       From
                                                            March 31,              Inception to
                                               ------------------------------        March 31,
                                                   2005               2004             2005
                                               ------------      ------------      ------------
<S>                                            <C>               <C>               <C>
Revenues, net                                  $     19,249      $      9,178      $     95,017

Cost of revenues                                      9,328                --            18,490
                                               ------------      ------------      ------------

Gross profit                                          9,921             9,178            76,527
                                               ------------      ------------      ------------

Operating expenses:
     DVD production costs                            36,519            29,220           414,499
     General and administration                     172,570           380,795         2,562,756
     Sales and marketing                            120,410           104,451         1,291,111
     Depreciation and amortization                    1,227               699           150,708
                                               ------------      ------------      ------------
          Total operating expense                   330,726           515,165         4,419,074
                                               ------------      ------------      ------------

Operating loss                                     (320,805)         (505,987)       (4,342,547)
                                               ------------      ------------      ------------

Other income and (expense)
     Interest expense                              (147,136)          (70,275)         (704,200)
     Interest income                                     74               191             1,581
     Other income                                       951                --             2,437
     Gain on sale of subsidiary                          --                --             2,421
                                               ------------      ------------      ------------
          Total other income (expense)             (146,111)          (70,084)         (697,761)
                                               ------------      ------------      ------------

Loss before extraordinary items                    (466,916)         (576,071)       (5,040,308)

     Gain on extinguishment of debt                      --                --             1,404
                                               ------------      ------------      ------------

Loss before taxes                                  (466,916)         (576,071)       (5,038,904)

     Provision for income taxes                          --                --                --
                                               ------------      ------------      ------------

Net loss                                       $   (466,916)     $   (576,071)     $ (5,038,904)
                                               ============      ============      ============

Net loss per share, basic and diluted                ($0.04)           ($0.05)           ($0.96)
                                               ============      ============      ============

Weighted average shares, basic and diluted       13,091,685        12,038,292         5,229,528
                                               ============      ============      ============
</TABLE>

                       See Notes to Financial Statements.


                                       5
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                     f/k/a PetCARE Television Network, Inc.
                          (A DEVELOPMENT STAGE COMPANY)
                       STATEMENTS OF STOCKHOLDERS' EQUITY
       FOR PERIOD FROM INCEPTION (OCTOBER 2, 1989) THROUGH MARCH 31, 2005

<TABLE>
<CAPTION>


                                                 Preferred Stock             Common Stock          Additional
                                           -------------------------   -------------------------     Paid-in    Subscription
                                              Shares        Amount        Shares       Amount        Capital     Receivable
                                           -----------   -----------   -----------   -----------   -----------   -----------
<S>                                        <C>           <C>            <C>          <C>           <C>           <C>
Issuance of $0.01 par value common
  shares to an individual for a note                --   $        --         1,000   $       100   $     1,900   $    (2,000)
Payment of subscription receivable                  --            --            --            --            --         1,885
Stock split 2,000:1 and change par                  --            --            --            --            --            --
 value from $0.01 to $0.0005                        --            --     1,999,000           900          (900)           --
                                           -----------   -----------   -----------   -----------   -----------   -----------
Balance, December 31, 1996                          --            --     2,000,000         1,000         1,000          (115)

Repurchase of shares                                --            --            --            --            --            --
Issuance of common stock                            --            --     2,476,000         1,238         3,762        (5,000)
                                           -----------   -----------   -----------   -----------   -----------   -----------
Balance, December 31, 1997                          --            --     4,476,000         2,238         4,762        (5,115)

Net loss                                            --            --            --            --            --            --
                                           -----------   -----------   -----------   -----------   -----------   -----------
Balance, December 31, 1998                          --            --     4,476,000         2,238         4,762        (5,115)
                                           -----------   -----------   -----------   -----------   -----------   -----------

Balance, December 31, 1999                          --            --     4,476,000         2,238         4,762        (5,115)

Shares issued in connection
 with merger with Y2K Recording, Inc.               --            --     1,025,000           513            --            --
Net income                                          --            --            --            --            --            --
                                           -----------   -----------   -----------   -----------   -----------   -----------
Balance, December 31, 2000                          --            --     5,501,000         2,751         4,762        (5,115)

Shares issued in connection
 with merger with Savage Mojo, Inc.                 --            --     8,000,000         4,000            --            --
Shares issued for services                          --            --        10,000             5           995            --
Contributed capital                                 --            --            --            --         5,672            --
Net loss                                            --            --            --            --            --            --
                                           -----------   -----------   -----------   -----------   -----------   -----------
Balance, December 31, 2001                          --            --    13,511,000         6,756        11,429        (5,115)

Series A shares sold in private placement       47,750        95,500            --            --            --            --
Retire treasury stock                               --            --    (1,725,000)         (863)       (4,137)           --
Shares issued as premium for notes                  --            --     2,939,553         1,470            --            --
Shares issued for Cohen employment
 agreement                                          --            --       748,447           374        74,471            --
Cancellation of outstanding stock
 returned by M. Klimes                              --            --    (4,000,000)       (2,000)           --            --
Shares issued for services                          --            --       312,000           156        31,044            --
Payment of subscription receivable                  --            --            --            --            --         5,000
Write off of subscription receivable                                                                                     115
Net loss                                            --            --            --            --            --            --
                                           -----------   -----------   -----------   -----------   -----------   -----------
Balance, December 31, 2002                      47,750        95,500    11,786,000         5,893       112,807            --

Shares issued for services                          --            --        50,000            25         4,975            --
Series A shares sold in private placement       53,500       107,000            --            --            --            --
Series B shares sold in private placement        1,000         2,000            --            --            --            --
Net loss                                            --            --            --            --            --            --
                                           -----------   -----------   -----------   -----------   -----------   -----------
Balance, December 31, 2003                     102,250       204,500    11,836,000         5,918       117,782            --

Conversion of Series A to common              (101,250)     (202,500)      525,959           263       202,237            --
Cancellation and refund of Series B             (1,000)       (2,000)           --            --            --            --
Shares issued for services                          --            --       372,583           186       101,828            --
Shares issued for debt                              --            --       357,143           179       249,821            --
Net loss                                            --            --            --            --            --            --
                                           -----------   -----------   -----------   -----------   -----------   -----------
Balance, December 31, 2004                          --            --    13,091,685                     671,668

Net loss                                            --            --            --            --            --            --
                                           -----------   -----------   -----------   -----------   -----------   -----------
Balance, March 31, 2005                             --   $        --    13,091,685   $     6,546   $   671,668   $        --
                                           ===========   ===========   ===========   ===========   ===========   ===========

<CAPTION>

                                             Accumulated
                                           Deficit during      Treasury Stock
                                             Development   -------------------------
                                                Stage        Shares        Amount         Total
                                             -----------   -----------   -----------   -----------
<S>                                          <C>           <C>           <C>           <C>
Issuance of $0.01 par value common
  shares to an individual for a note         $        --            --            --   $        --
Payment of subscription receivable                    --            --            --         1,885
Stock split 2,000:1 and change par                    --            --            --            --
 value from $0.01 to $0.0005                          --            --            --            --
                                             -----------   -----------   -----------   -----------
Balance, December 31, 1996                            --            --            --         1,885

Repurchase of shares                                  --    (1,725,000)       (5,000)       (5,000)
Issuance of common stock                              --            --            --            --
                                             -----------   -----------   -----------   -----------
Balance, December 31, 1997                            --    (1,725,000)       (5,000)       (3,115)

Net loss                                          (2,867)           --            --        (2,867)
                                             -----------   -----------   -----------   -----------
Balance, December 31, 1998                        (2,867)   (1,725,000)       (5,000)       (5,982)
                                             -----------   -----------   -----------   -----------

Balance, December 31, 1999                        (2,867)   (1,725,000)       (5,000)       (5,982)

Shares issued in connection
 with merger with Y2K Recording, Inc.                 --            --            --           513
Net income                                           434            --            --           434
                                             -----------   -----------   -----------   -----------
Balance, December 31, 2000                        (2,433)   (1,725,000)       (5,000)       (5,035)

Shares issued in connection
 with merger with Savage Mojo, Inc.                   --            --            --         4,000
Shares issued for services                            --            --            --         1,000
Contributed capital                                   --            --            --         5,672
Net loss                                         (57,151)           --            --       (57,151)
                                             -----------   -----------   -----------   -----------
Balance, December 31, 2001                       (59,584)   (1,725,000)       (5,000)      (51,514)

Series A shares sold in private placement             --            --            --        95,500
Retire treasury stock                                 --     1,725,000         5,000            --
Shares issued as premium for notes                    --            --            --         1,470
Shares issued for Cohen employment
 agreement                                            --            --            --        74,845
Cancellation of outstanding stock
 returned by M. Klimes                                --            --            --        (2,000)
Shares issued for services                            --            --            --        31,200
Payment of subscription receivable                    --            --            --         5,000
Write off of subscription receivable                                                           115
Net loss                                        (498,888)           --            --      (498,888)
                                             -----------   -----------   -----------   -----------
Balance, December 31, 2002                      (558,472)           --            --      (344,272)

Shares issued for services                            --            --            --         5,000
Series A shares sold in private placement             --            --            --       107,000
Series B shares sold in private placement             --            --            --         2,000
Net loss                                      (1,825,313)           --            --    (1,825,313)
                                             -----------   -----------   -----------   -----------
Balance, December 31, 2003                    (2,383,785)           --            --    (2,055,585)

Conversion of Series A to common                      --            --            --            --
Cancellation and refund of Series B                   --            --            --        (2,000)
Shares issued for services                            --            --            --       102,014
Shares issued for debt                                --            --            --       250,000
Net loss                                      (2,188,203)           --            --    (2,188,203)
                                             -----------   -----------   -----------   -----------
Balance, December 31, 2004                    (4,571,988)           --            --    (3,893,774)

Net loss                                        (466,916)           --            --      (466,916)
                                             -----------   -----------   -----------   -----------
Balance, March 31, 2005                      $(5,038,904)  $        --   $        --   $(4,360,690)
                                             ===========   ===========   ===========   ===========
</TABLE>

                       See Notes to Financial Statements.


                                       6
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                     f/k/a PetCARE Television Network, Inc.
                          (A DEVELOPMENT STAGE COMPANY)
                       UNAUDITED STATEMENTS OF CASH FLOWS
               FOR THE THREE MONTHS ENDED MARCH 31, 2005 AND 2004
               FROM INCEPTION (OCTOBER 2, 1989) TO MARCH 31, 2005

<TABLE>
<CAPTION>
                                                                                                         From
                                                                             March 31,              Inception to
                                                                   ----------------------------       March 31,
                                                                       2005             2004             2005
                                                                   -----------      -----------      -----------
<S>                                                                <C>              <C>              <C>
CASH FLOWS FROM OPERATING ACTIVITES
  Net loss                                                         $  (466,916)     $  (576,071)     $(5,038,904)
     Adjustments to reconcile net loss to net cash flows from
        operating activities:
          Depreciation and amortization expense                          1,227              699           13,782
          Gain on sale of subsidiary                                        --               --           (2,421)
          Gain on extinguishment of debt                                    --               --           (1,404)
          Compensation expense - stock for services                         --               --          106,045
          Bad debt expense - write off subscription receivable              --                            10,115
          Changes in assets and liabilities:
             Accounts receivable                                         9,170           (8,500)         (10,300)
             Prepaid expenses                                           28,026           (7,059)         (49,485)
             Other receivables                                         (19,630)          (6,484)         (20,364)
             Security deposits                                              --               --           (7,596)
             Accounts payable                                           39,875          111,508           97,726
             Accrued expenses and other current liabilities            196,956         (170,144)         614,449
                                                                   -----------      -----------      -----------

Net cash flows (used) in operating activities                         (211,292)        (656,051)      (4,288,357)
                                                                   -----------      -----------      -----------

CASH FLOWS FROM INVESTING ACTIVITIES
  Purchase of equipment                                                     --           (5,646)         (16,961)
                                                                   -----------      -----------      -----------

Net cash flows (used) in investing activities                               --           (5,646)         (16,961)
                                                                   -----------      -----------      -----------

CASH FLOWS FROM FINANCING ACTIVITIES
  Common stock issued                                                       --               --           14,185
  Common stock issued for debt                                              --               --          250,000
  Common stock issued for services                                          --               --          102,014
  Common stock subscriptions (issued) paid                                  --               --             (115)
  Preferred stock issued (redeemed)                                         --               --          202,500
  Proceeds from notes payable                                          250,000        1,000,000        1,625,000
  Proceeds from loans from stockholders-net                                 --          (69,500)       2,169,235
                                                                   -----------      -----------      -----------

Net cash flows provided by financing activities                        250,000          930,500        4,362,819
                                                                   -----------      -----------      -----------

Decrease in cash                                                        38,708          268,803           57,501
Cash, beginning of period                                               18,793               --               --
                                                                   -----------      -----------      -----------
Cash, end of period                                                $    57,501      $   268,803      $    57,501
                                                                   ===========      ===========      ===========

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:

Cash paid for interest                                             $       253      $     2,010      $     5,769
                                                                   ===========      ===========      ===========
</TABLE>

                       See Notes to Financial Statements.


                                       7
<PAGE>

NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

On April 21, 2005, PetCARE Television Network,  Inc. changed its name to Medical
Media  Television,  Inc.  ("Medical Media" or the "Company").  Medical Media was
organized  as a Florida  corporation  on  October 2,  1989.  On April 22,  2005,
Medical Media organized a wholly owned subsidiary,  PetCARE Television  Network,
Inc., a Florida corporation. Also on April 22, 2005 Medical Media organized AAMN
Acquisition Sub, Inc. a wholly owned Florida  corporation,  the purpose of which
is more  fully  discussed  in NOTE F -  SUBSEQUENT  EVENTS.  Medical  Media is a
development  stage  company,  and as such has  devoted  its  efforts  since  its
inception in developing and  implementing  its business plan, which includes but
is not limited to  establishing  a  subscriber  network of  approximately  3,000
veterinary  clinics  and  hospitals,  writing  and  producing  its  monthly  DVD
magazines, making contacts with potential advertisers, obtaining debt and equity
financing,   establishing   its  accounting   systems,   and  performing   other
administrative  functions.  The Company's primary goal is to provide educational
programming, targeted to pet owners worldwide, focused on optimal healthcare for
animal companions.  The Company's programming is obtained through a one or three
year  subscription,  with a TV/DVD system  included in the three-year  plan. The
Company's  updated  DVD  magazines  are  shipped  monthly  to  all  veterinarian
subscribers and are funded, in part, by commercial  advertisers  included on the
DVD magazines.

Basis of Accounting

Medical Media  maintains its financial  records and financial  statements on the
accrual basis of  accounting.  The accrual  basis of  accounting  provides for a
better matching of revenues and expenses.

Interim Information

The  accompanying  unaudited  financial  statements  of Medical  Media have been
prepared in accordance  with  accounting  principles  generally  accepted in the
United  States  of  America  for  interim  financial  information  and  with the
instructions to Form 10-QSB and Rule 10-01 of Regulation  S-X. All  adjustments,
which,  in the opinion of management,  are necessary for a fair  presentation of
the financial condition and results of operations, have been included. Operating
results for the three  month  period  ended  March 31, 2005 are not  necessarily
indicative of the results that may be expected for the year ending  December 31,
2005.

Cash and Cash Equivalents

For purposes of the Statements of Cash Flows,  Medical Media  considers  amounts
held by  financial  institutions  and  short-term  investments  with an original
maturity of 90 days or less to be cash and cash equivalents.

Fiscal Year

Medical Media elected December 31 as its fiscal year.

Revenue Recognition

The Company  generates revenue from two primary sources,  namely  advertisers on
its DVD  magazines  (the  "Advertisers")  and  subscribers  to its network  (the
"Subscribers").  With regard to Advertisers, the Company recognizes revenue over
the periods in which the  advertisers'  commercials  appear on its DVD magazine.
With  regard to  Subscribers,  revenue is  recognized  proportionately  over the
length of the subscription agreement entered into by the Subscribers.


                                       8
<PAGE>

NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Income Taxes

Medical Media  records its federal and state tax  liability in  accordance  with
Financial  Accounting  Standards  Board Statement No. 109 "Accounting for Income
Taxes".  The  deferred  taxes  payable are recorded  for  temporary  differences
between the  recognition of income and expenses for tax and financial  reporting
purposes, using current tax rates. Deferred assets and liabilities represent the
future tax  consequences of those  differences,  which will either be taxable or
deductible when the assets and liabilities are recovered or settled.

Since its  inception,  Medical Media has an  accumulated  loss of $5,006,712 for
income tax purposes,  which can be used to offset future  taxable income through
2023. The potential tax benefit of this loss is as follows:

      Future tax benefit                                          $ 1,502,014
      Valuation allowance                                          (1,502,014)
                                                                  -----------

      Future tax benefit                                          $        --
                                                                  ===========

As of March 31,  2005,  no  deferred  taxes were  recorded  in the  accompanying
financial statements.

Advertising Costs

Medical Media  expenses the production  costs of advertising  the first time the
advertising takes place.

Fixed Assets

Medical  Media's fixed assets consist of computer  equipment  being  depreciated
over 3 years and leasehold  improvements  being  depreciated  over the remaining
life of the current lease.

Going Concern

Medical Media Television Network,  Inc. f/k/a PetCARE Television  Network,  Inc.
was organized as a Florida  corporation  on October 2, 1989 and is a development
stage company, and as such, as devoted its efforts since inception to developing
and implementing its business plan. Realization of a major portion of the assets
is  dependent  upon  the  Company's   ability  to  meet  its  future   financing
requirements, and the success of future operations.

Use of Estimates

The preparation of financial  statements in conformity  with generally  accepted
accounting principles requires management to make estimates and assumptions that
affect  the  reported  amounts  of assets  and  liabilities  and  disclosure  of
contingent  assets and  liabilities at the date of the financial  statements and
the  reported  amounts of revenues  and expenses  during the  reporting  period.
Actual results could differ from those estimates.

NOTE B - COMMON AND PREFERRED STOCK

Start of trading on the OTC Bulletin Board

On  February  2,  2004,  Medical  Media's  common  stock  began  trading  on the
OTC-Bulletin  Board under the symbol PTNW. As a result of the  Company's  recent
corporate name change to Medical Media  Television,  Inc., the Company's  common
stock is now  traded  under the  symbol of MMTV.  There is a


                                       9
<PAGE>

NOTE B - COMMON AND PREFERRED STOCK (Continued)

limited public  trading  market for its common stock and a regular,  more active
trading market may not develop, or if developed, may not be sustained.

Issuance of Common Stock

In February  2004,  Medical  Media  entered into a Note  Purchase  Agreement and
Subordinated  Convertible  Promissory  Note (the  "February  Note")  with Victus
Capital, LP, a Delaware limited partnership  ("Victus").  Under the terms of the
February Note,  Victus loaned Medical Media  $1,000,000 with interest of $62,500
per quarter.  In order to insure that interest  payments were made,  $250,000 of
the  principal  amount of the February  Note was delivered to an escrow agent to
hold for the purposes of making quarterly interest payments to Victus.  Prior to
the  maturity  date of the February  Note,  Victus has the option to convert the
principal and any outstanding interest into shares of a future private offering,
or into shares of the Company's Common Stock at a price of $.375 per share. Upon
acceleration  or  conversion  of the February  Note,  any unpaid  balance in the
escrow  account would be returned to Victus.  In May 2004,  Medical Media issued
357,143  shares of its Common  Stock at $.70 per share and 714,286  Common Stock
Purchase  Warrants in lieu of $250,000 in  interest  due on the  February  Note.
Accordingly,  the  $250,000  being held in escrow was released to the Company in
exchange  for the shares and  warrants.  Each  warrant is  exercisable  into the
Company's  Common Stock at $1.00 per share.  The warrants are exercisable at any
time for five years from the date of issuance.  The February Note,  shares,  and
warrants were issued under the exemption from  registration  provided in Section
4(2) of the Securities Act of 1933 (the "Securities  Act"). In March 2005, Vicis
Capital, LP, a Delaware limited partnership ("Vicis") acquired certain assets of
Victus.  Included in the acquisition were the February-Note,  the 357,143 shares
of Common Stock of Medical Media, and the 714,286 Common Stock Purchase Warrants
discussed above.

In April 2004, Medical Media issued 67,583 shares of Common Stock to two vendors
in exchange for debt recorded as accounts payable on the accompanying  financial
statements.  The shares of Common  Stock were issued  under the  exemption  from
registration provided in Section 4(2) of the Securities Act.

In May 2004,  Medical Media issued 533,333 warrants to purchase its Common Stock
in  accordance  with the Placement  Agent Fee  agreement  entered into with H.C.
Wainwright,  Inc.,  dated February 2004. The warrants  became due as a result of
the funds  raised in  conjunction  with the Victus  Note  discussed  above.  The
warrants were issued under the exemption from  registration  provided in Section
4(2) of the Securities Act.

In June 2004,  the Company  issued 250,000 shares of Common Stock to a vendor in
exchange for debt.  The shares of Common  Stock were issued under the  exemption
from registration provided in Section 4(2) of the Securities Act

During the three months ended June 30 2004,  the Company issued 55,000 shares of
Common Stock to members of its Veterinary Advisory Board.

On July 28, 2004, the Company  entered into a seven-month  financial  consulting
agreement with TotalCFO,  Inc.  ("TotalCFO").  In connection with the consulting
agreement,  the Company agreed to issue 300,000  warrants to purchase its common
stock (the "TotalCFO Warrants") in exchange for the services to be rendered. The
TotalCFO  Warrants were issued in September 2004. The warrants were issued under
the exemption from registration provided in Section 4(2) of the Securities Act.


                                       10
<PAGE>

NOTE B - COMMON AND PREFERRED STOCK (Continued)

Series B Convertible Preferred Stock

On  October  21,  2003,  the  Board of  Directors  of  Medical  Media  adopted a
resolution  providing  for  the  creation  of  Medical  Media's  Certificate  of
Designation,  Preferences,  Rights and  Limitations for its Series B Convertible
Preferred  Stock  ("Series B Stock").  As a result of this  resolution,  Medical
Media had 1,000,000 no par value preferred shares authorized.  In November 2003,
Medical Media offered  1,000,000 of its Series B Stock in a private placement of
units  consisting  of one share of Series B Stock and one  warrant  to  purchase
common stock of the Company for $2.00 per unit.  After only selling  1,000 units
for the  purchase  price of  $2,000,  the  Company  decided to  discontinue  the
offering.  In May  2004,  the  Company  refunded  the  $2,000  paid by the  sole
shareholder  of Series B Stock.  The  offering  is  claimed  to be exempt  under
Section 4(2) of the Securities Act.

On May 18, 2004,  the Board of Directors of Medical  Media  adopted a resolution
providing  for the  amendment of Medical  Media's  Certificate  of  Designation,
Preferences, Rights and Limitations for its Series B Convertible Preferred Stock
("Series B Preferred Stock"). As a result of this resolution,  Medical Media has
1,500,000 no par value preferred shares authorized. These shares are convertible
into the  Company's  Common Stock at any time  commencing  one (1) year from the
date of issuance. Each share of Series B Preferred Stock converts into shares of
the Company's Common Stock at the variable  conversion price equal to 70% of the
average  closing  price as reported by  Bloomberg  L.P.  for the 20 trading days
preceding  the date of  conversion.  However,  in no event shall the  conversion
price be less than  $0.50 per share,  nor  greater  than  $1.50 per  share.  The
holders of the Series B Preferred  Stock will be entitled to dividends of 8% per
annum,  payable in one payment upon conversion of the Series B Preferred  Stock.
In

In June 2004, Medical Media offered 1,500,000 of its Series B Preferred Stock in
a private placement of units consisting of one share of Series B Preferred Stock
and one warrant to purchase  common stock of the Company for $1.00 per unit.  At
the time of this filing,  no units have been sold. The offering is claimed to be
exempt under Section 4(2) of the Securities Act.

Stock Options

Medical  Media has an equity  incentive  plan  available  to key  employees  and
consultants of the Company.  Under the plan, Medical Media may grant options for
up to two million  shares of common stock.  The exercise price of each incentive
option is equal to the greater of the fair market value of Medical Media's stock
on the date of  grant or the  aggregate  par  value of the  stock on the date of
grant. In the case of any 10%  stockholder,  the incentive option price will not
be  less  than  110%  of the  fair  market  value  on the  date  of  grant.  The
Compensation  Committee of the Board of Directors  shall  determine the price at
which  shares of stock may be purchased  under a  nonqualified  option.  Options
expire  ten years  from the date of grant,  except  for those  granted  to a 10%
stockholder,  which expire five years from the date of grant.  To date,  Medical
Media has granted 159,000 nonqualified options under the plan.

NOTE C - RELATED PARTY TRANSACTIONS

Medical  Media has in place a  consulting  agreement,  dated June 1, 2002,  with
James Calaway, a former director of the Company, which states that Medical Media
will pay that  director  $667 per month until  Medical  Media has received  $2.5
million in equity  funding.  As of March 31,  2005,  Medical  Media had received
$204,500 in equity funding. Management believes it will receive the remainder of
the $2.5 million in funding within the next twelve months.


                                       11
<PAGE>

NOTE C - RELATED PARTY TRANSACTIONS (Continued)

In May and June 2002,  Medical Media issued the following  non-interest  bearing
promissory notes:

      o     James Calaway,  a former director,  in the original principal amount
            of $100,000, current balance $91,500

      o     Daniel  V.  Hugo,  a former  officer  and  former  director,  in the
            original principal amount of $25,000

      o     Robert and Janna Hugo in the original principal amount of $6,000

      o     Robert and Jamie Turner in the original principal amount of $5,000

The  repayment of these notes is contingent  upon the receipt of funds  received
through  private  placement  transactions  pursuant to Rule 506,  with  periodic
payments to be made to the holders as follows:  10% due after the first $300,000
is received; 10% due after the next $100,000 is received; 10% due after the next
$100,000  is  received,  35% due after the next  $100,000 is  received;  and the
remaining 35% due after the next  $100,000 is received.  As of December 31, 2004
and March 31, 2005, the aggregate principal balance on these notes was $127,500.

On March 10, 2003,  May 28, 2003,  June 6, 2003,  and July 1, 2003 Medical Media
entered into note purchase and security  agreements  (the "Edge Notes") with Pet
Edge, LLC, a Connecticut limited liability company ("Edge").  Edge was organized
for the sole purpose of funding the Company's  business plan. Under the terms of
the Edge Notes,  Edge  loaned the  Company  $1,000,000,  $50,000,  $50,000,  and
$275,000 respectively with simple interest at the rate of ten percent per annum.
All principal and accrued  interest on the Edge Notes is due March 9, 2006,  May
27, 2006,  June 5, 2006,  and June 30, 2006  respectively.  The notes may not be
prepaid in whole or in part without the written  consent of Edge.  To secure the
Company's obligations under the notes, the Company granted Edge a first priority
security interest on all of its assets now owned and acquired during the term of
the Edge Notes. The principal and interest on the Edge Notes is convertible into
shares of common stock of the Company at $.246 per share.  On November 10, 2003,
Medical  Media  entered  into an  agreement  with  Edge to  amend  the  terms of
conversion of their notes issued on March 10, 2003, May 28, 2003,  June 6, 2003,
and July 1, 2003. Under the terms of the agreement,  the conversion price on the
respective notes totaling  $1,375,000 shall provide that if shares,  in segments
of not less than  $250,000,  are converted  before one year from the date of the
agreement, the conversion price will be $0.214 per share, and if converted after
one year from the date of the  agreement  and  before two years from the date of
the agreement, the conversion price will be $0.23 per share.

On June 10, 2003,  Medical Media entered into a note purchase agreement with one
of its directors,  Dr. Mark Maltzer (the "Maltzer Note"). Under the terms of the
Maltzer  Note,  Dr.  Maltzer  agreed to loan Medical  Media  $50,000 with simple
interest at a rate of ten percent per annum.  All principal and accrued interest
is due  June  9,  2006.  The  principal  and  interest  on the  Maltzer  Note is
convertible into shares of its common stock at $.246 per share.

On June 5, 2002, Medical Media entered into an employment  agreement with Philip
M. Cohen that has an infinite term.  This agreement  automatically  renews every
ninety days commencing  June 5, 2002.  Medical Media may terminate the agreement
with cause, effective upon delivery of written notice to Mr. Cohen, except where
the cause is a material breach of this agreement,  for which Mr. Cohen has sixty
(60) days to cure the material  breach after written  notice from Medical Media.
Medical Media may terminate this agreement  without cause,  effective sixty (60)
days after written  notice to Mr. Cohen.  Mr. Cohen may terminate this agreement
with cause provided he delivers  written notice to Medical Media sixty (60) days
before  termination,  or without cause  provided he delivers  written notice one
year before  termination.  If Medical Media  terminates  the  agreement  without
cause, or Mr. Cohen terminates the agreement with


                                       12
<PAGE>

NOTE C - RELATED PARTY TRANSACTIONS (Continued)

cause,  Medical  Media  will be  obligated  to pay Mr.  Cohen the  compensation,
remuneration  and expenses  specified  below for a period of five years from the
date of notice.  Under the terms of the  agreement,  Mr.  Cohen will  receive an
annual  salary of $150,000,  payable in monthly  installments  of $12,500.  This
salary will be  renegotiated  at the end of each fiscal year. The salary was not
renegotiated at the end of fiscal year 2002,  2003, or 2004. Mr. Cohen will also
receive medical and long-term  disability insurance at the Company's expense, as
well as an automobile for business use, and  reimbursement  for certain business
expenses.

On August 19, 2003,  Medical  Media  entered  into a sixty-two  (62) month lease
agreement   commencing  on  October  1,  2003  with  Liberty   Property  Limited
Partnership  for  approximately  3,800  square  feet of  office/warehouse  space
located at 8406 Benjamin Road, Suite C, Tampa,  Florida 33634. Lease expense for
2004 totaled $38,593.  Under this agreement,  projected lease expense for the 12
months ended December 31, 2005 through 2007 and the eleven months ended November
30,  2008  will  be  approximately   $39,400,   $40,300,   $41,100  and  $38,500
respectively.

NOTE D - SUBORDINATED CONVERTIBLE PROMISSORY NOTE

On February 13, 2004,  Medical Media entered into a Note Purchase  Agreement and
Subordinated  Convertible Promissory Note ("February Note") with Victus Capital,
LP,  a  Delaware  limited  partnership  ("Victus").  Under  the  terms  of  this
twelve-month note, Victus loaned the Company $1,000,000 with interest of $62,500
or 6.25% per  quarter.  In order to insure  that  interest  payments  were made,
$250,000 of the principal amount of the February Note was delivered to an escrow
agent to hold for the purposes of making quarterly  interest payments to Victus.
Prior to the  maturity  date of the  February  Note,  Victus  has the  option to
convert  the  principal  and any  outstanding  interest  into shares of a future
private  offering,  or into shares of the  Company's  common stock at a price of
$0.375 per share.  Upon  acceleration  or conversion of the February  Note,  any
unpaid balance in the escrow account would be returned to Victus.  In May, 2004,
the Company entered into a Debt Conversion  Agreement  ("Conversion  Agreement")
with Victus  whereby the Company agreed to issue Victus 357,143 shares of Common
Stock and 714,286 Common Stock Purchase Warrants (exercisable at $1.00 per share
at any time  for five  years  from  the  date of  issuance)  in lieu of the cash
payments of interest on the February  Note.  Simultaneous  with the execution of
the Conversion Agreement, the funds previously held in escrow were released from
escrow and  forwarded  to the  Company.  In March  2005,  Vicis  Capital,  LP, a
Delaware  limited  partnership  ("Vicis"),  acquired  certain  assets of Victus.
Included in the acquisition were the February-Note, the 357,143 shares of Common
Stock of Medical Media,  and 714,286  pre-split  Common Stock Purchase  Warrants
discussed above.

On July  27,  2004,  Medical  Media  and  Victus  entered  into a Note  Purchase
Agreement ("NPA"),  Subordinated  Convertible Promissory Note ("July Note"), and
Warrant to Purchase  Shares of Common Stock (the  "Warrant").  On July 28, 2004,
pursuant  to the terms of the NPA and the July Note,  Victus  loaned the Company
$1,000,000,  at an annual rate of interest of twenty  percent  (20%)  compounded
semi-annually.  The July  Note has a term of  twelve  months;  however  with the
consent  of both  parties,  the term of the July  Note  can be  extended  for an
additional  12 months.  For the first year,  the Company shall have the right to
pay interest on the July Note with registered,  freely transferable common stock
of the Company,  valued at a ten percent  (10%)  discount to the market.  On the
date of maturity of the July Note, the July Note is  convertible,  at the option
of the holder,  into shares of the Company's common stock at a price of $.40 per
share. Pursuant to the terms of the Warrant, Victus may purchase up to 2,500,000
shares of common  stock of the Company at an exercise  price of $0.75 per share.
The Warrant expires on July 26, 2009. The July Note may not be converted and the
Warrant may not be exercised to the extent that Victus' overall ownership of the
common


                                       13
<PAGE>

NOTE D - SUBORDINATED CONVERTIBLE PROMISSORY NOTE (Continued)

stock of the Company  will exceed  4.99%,  unless such  limitation  is waived by
Victus upon no less than sixty-one days (61) advance  written  notice.  In March
2005, Vicis acquired certain assets of Victus.  Included in the acquisition were
the Victus July Note and the Warrant discussed above.

On March 11, 2005,  Medical Media Television  Network,  Inc. (the "Company") and
Vicis  entered  into Series A  Convertible  Debentures  ("Debenture"),  Series A
Common Stock Purchase  Warrants,  Series B Common Stock Purchase  Warrants,  and
Series  C  Common  Stock  Purchase  Warrants.  Pursuant  to  the  terms  of  the
Debentures, Vicis loaned the Company an aggregate of $250,000, at an annual rate
of interest of fifteen  percent (15%).  The Debentures  have a term of 24 months
and the Company has the option to pay the interest  semi-annually  in cash or in
shares of its  registered  Common Stock at a ten percent  (10%)  discount to the
market  price based on the average of the twenty (20)  trading days prior to the
payment of the interest.  On the date of maturity of the Debentures,  the holder
has the option to convert into shares of the  Company's  Common Stock at a price
of $0.10 per share.  Pursuant to the terms of the Series A Common Stock Purchase
Warrants,  Vicis may  purchase  up to  2,500,000  shares of common  stock of the
Company at an exercise price of $0.10 per share for a ten-year period. Under the
terms of the Series B Common Stock  Purchase  Warrants  Vicis may purchase up to
2,500,000  shares of common  stock of the Company at an exercise  price of $0.11
per share for a five-year  period.  Under the terms of the Series C Common Stock
Purchase  Warrants Vicis may purchase up to 1,250,000  shares of common stock of
the Company at an exercise  price of $.10 per share for a one-year  period.  The
Debentures  and Series A, B, and C Common  Stock  Purchase  Warrants  may not be
converted  and  exercised  to the extent that Vicis'  overall  ownership  of the
Common Stock of the Company will exceed 4.99%,  unless such limitation is waived
by Vicis upon no less than sixty-one days (61) advance written notice.

NOTE E - SUBSEQUENT EVENTS

A Written Action of a Majority of the  Shareholders  in Lieu of Special  Meeting
was signed on April 6, 2005,  in which  7,079,471  shares of the total shares of
the Common Stock  outstanding of 13,091,685  (54.07%) approved the Memorandum of
Terms for the Company's acquisition of African American Medical Network, Inc., a
wholly-owned  subsidiary of AFMN,  Inc. and  authorized  the Company's  Board of
Directors to (i) change the  Company's  corporate  name from PetCARE  Television
Network,  Inc. to Medical  Media  Television,  Inc.;  (ii) combine the Company's
issued and outstanding Common Stock on a 1:30 basis effective as of May 4, 2005;
and  (iii)  declare  and issue a  dividend  of two (2)  shares of the  Company's
restricted  common stock for each share of common stock held by  shareholders of
record as of May 10, 2005.

On May 6, 2005, the Company issued its Series B Convertible  Debentures ("Series
B Debentures") to Vicis Capital Master Series Trust ("Vicis"), a fund managed by
Vicis Capital,  LP, a Delaware  limited  partnership,  pursuant to the exemption
from  registration  found in Section 4(2) of Regulation D as  promulgated by the
Securities and Exchange Commission under the Securities Act of 1933. Pursuant to
the terms of the Series B  Debentures,  Vicis loaned the Company an aggregate of
$250,000,  at an annual rate of interest of fifteen percent (15%).  The Series B
Debentures  have a term of 24 months and the  Company  has the option to pay the
interest  semi-annually in cash or in shares of its registered Common Stock at a
ten percent  (10%)  discount to the market  price based on the average  five (5)
days Volume Weighted Average Closing Price of the Company's common stock for the
five (5) trading days prior to payment.  On the date of maturity of the Series B
Debentures,  the holder has the option to convert  into shares of the  Company's
Common Stock at a price of $2.40 per share (post-split).

In addition to, and in connection  with, the foregoing,  the Company also issued
its Series D Common Stock  Purchase  Warrants,  Series E Common  Stock  Purchase
Warrants, and Series F Common Stock


                                       14
<PAGE>

NOTE E - SUBSEQUENT EVENTS (Continued)

Purchase  Warrants to Vicis.  Pursuant to the terms of the Series D Common Stock
Purchase  Warrants,  Vicis may  purchase up to 104,167  shares of the  Company's
Common Stock at an exercise price of $2.40 per share for a ten (10) year period.
Under  the  terms of the  Series E Common  Stock  Purchase  Warrants,  Vicis may
purchase up to 104,167 shares of the Company's Common Stock at an exercise price
of $2.40 per share for a five- (5) year period.  Under the terms of the Series F
Common Stock Purchase  Warrants,  Vicis may purchase up to 104,167 shares of the
Company's  Common  Stock at an exercise  price of $2.40 per share for a one-year
period.  The Series B Debentures  and Series D, E, and F Common  Stock  Purchase
Warrants may not be converted  and  exercised to the extent that Vicis'  overall
ownership of the Common Stock of the Company  giving  effect to that  conversion
and together with the right to receive any common stock within sixty days of the
conversion  date will exceed 4.99% of the  Company's  outstanding  stock at that
time.

On May 11, 2005 the Company  executed that certain Merger Agreement (the "Merger
Agreement") by and among AFMN,  Inc. a Delaware  corporation  ("AFMN"),  African
American  Medical  Network,   Inc.  a  Florida  corporation  ("African  American
Medical"), and AAMN Acquisition Sub whereby the Company will acquire 100% of the
capital stock of African American  Medical in exchange for 14,865,657  shares of
its common stock. African American Medical provides  educational  programming to
patients through installation of viewing systems in doctor's offices serving the
African-American  population.  Pursuant  to the  terms  of the  Agreement,  AAMN
Acquisition Sub will be merged with and into African American Medical,  and AFMN
will receive the  aforementioned  shares of Medical Media in exchange for all of
the  outstanding  shares of capital stock of African  American  Medical owned by
AFMN. Pursuant to the terms of the Merger Agreement, the Company intends to file
a Registration Statement on Form S-4 with the Securities and Exchange Commission
(the  "SEC")  registering  the shares the  Company  intends to issue  AFMN.  The
closing of the Merger Agreement will occur within three (3) business days of the
date upon which the registration  statement on Form S-4 is declared effective by
the SEC, which will be filed as soon as practical.


                                       15
<PAGE>

Item 2.   Management's Discussion and Analysis or Plan of Operation.

Overview

      On April 21, 2005,  PetCARE Television  Network,  Inc. changed its name to
Medical Media Television, Inc. ("Medical Media" or the "Company";  references to
"we," "our" or "us" also mean the  Company).  Medical  Media was  organized as a
Florida  corporation  on October  2,  1989.  On April 22,  2005,  Medical  Media
organized a wholly-owned subsidiary, PetCARE Television Network, Inc., a Florida
corporation.  Also on April 22, 2005,  Medical Media organized AAMN  Acquisition
Sub, Inc., a wholly-owned  Florida  corporation  ("AAMN  Acquisition  Sub"), the
purpose of which is more fully discussed below in Item 5,  "Subsequent  Events."
We are a development stage company,  and as such, have devoted our efforts since
inception  to  developing  and   implementing   our  business  plan.  Since  the
commencement of the  implementation of our current business plan (June 2002), we
have devoted our efforts to the following activities:

      o     Raising capital;

      o     Producing our programming;

      o     Securing advertisers for our programming;

      o     Securing equipment;

      o     Producing marketing materials for veterinarians and advertisers;

      o     Contracting for subscription audits;

      o     Securing veterinary office locations to show our programming;

      o     Shipping equipment and educational programming to veterinarians; and

      o     Establishing a presence at trade shows.

      Our primary goal is to provide  educational  programming,  targeted to pet
owners worldwide, focused on optimal healthcare for animal companions. While pet
owners are seated in their  veterinarian's  reception  area, our DVD magazine is
played,  with an encouraging  theme  throughout each segment to "just ask" their
veterinarian  about current  techniques,  products and services  available.  The
programming is funded, in part, by commercial  advertisers that are reviewed and
approved by our Veterinary  Advisory Board, a distinguished  group of veterinary
professionals  committed to providing  quality  educational,  entertaining,  and
encouraging  veterinary health programming.  Our programming is obtained through
an annual or three-year  subscription,  with a TV/DVD viewing system included in
the  three-year   plan.   Updated  DVD  magazines  are  mailed  monthly  to  all
subscribers.

      We have  expended  approximately  $4,362,819  through  March  31,  2005 in
developing our business plan,  which included  placing systems in  approximately
3,000 veterinary  offices,  and the completion of production,  replication,  and
delivery of our monthly DVD magazines. For the period from the implementation of
our current  business plan (June 2002) through March 31, 2005, we have generated
$11,674 of revenue and $36,632 of deferred  revenue from  subscription  sales to
veterinarian offices,  $68,950 from advertising and $7,962 from sales of Welcome
Home Your New Friend (educational DVDs for new pet owners, sold to veterinarians
who distribute them to their clients).

      Our website  (www.petcaretv.com) was developed in cooperation with a third
party  consultant.  We use our  website  primarily  as an  information  tool for
prospective  subscribers  and  advertisers  who can log on to find out about our
business.  Prospective  subscribers are allowed to view our current programming,
review frequently asked questions,  review our subscription  process,  and print
out a subscription agreement.


                                       16
<PAGE>

Critical Accounting Policies and Estimates

      Our financial  statements have been prepared in accordance with accounting
principles  generally  accepted in the United States.  The  preparation of these
financial  statements  requires us to make  significant  estimates and judgments
that affect the reported amounts of assets, liabilities,  revenues, expenses and
related  disclosure  of  contingent  assets and  liabilities.  We  evaluate  our
estimates,  including  those related to  contingencies,  on an ongoing basis. We
base our estimates on  historical  experience  and on various other  assumptions
that are believed to be reasonable under the circumstances, the results of which
form the basis for  making  judgments  about the  carrying  values of assets and
liabilities that are not readily apparent from other sources. Actual results may
differ from these estimates under different assumptions or conditions.

Revenue Recognition

      We generate  revenue  from two  primary  sources:  advertisers  on our DVD
magazines   (the   "Advertisers")   and   subscribers   to  our   network   (the
"Subscribers").  With regard to Advertisers,  we recognize revenue in the period
in which the Advertisers' commercials appear on our DVD magazine. With regard to
Subscribers,  revenue  is  recognized  proportionately  over the  length  of the
subscription  agreement (1, 3, or 4 years)  entered into between the Company and
each Subscriber.

Plan of Operations

Results of Operations - Inception (October 2, 1989) to March 31, 2005

      From inception to March 31, 2005, we had losses totaling  $5,006,712.  For
this period, our general and  administrative  costs totaled $2,580,656 or 59% of
total operating  expenses.  DVD production costs totaled $414,499 or 9% of total
operating  expenses,  and sales and marketing costs totaled $1,274,240 or 29% of
total operating  expenses.  The remainder of operating expense is represented by
depreciation  and  amortization  that totaled  $150,708 or 3% of total operating
expenses.

Results of  Operations  - Comparison  of Three Months  Ending March 31, 2005 and
2004

      For the three month period ending March 31, 2005,  we had losses  totaling
$434,724,  compared  to  losses of  $576,071  for the same  period in 2004.  The
decrease of $141,347 is  primarily a result of fund raising  costs in 2004.  For
the three month period  ending March 31,  2005,  our general and  administration
costs totaled  $190,470,  compared to $380,795 for the same period in 2004. This
decrease of $190,325 is primarily  attributed  to fees and costs  related to our
fund raising efforts during 2004  ($155,000).  Our DVD production  costs totaled
$36,519 for the period  ending March 31, 2005,  compared to $29,220 for the same
period in 2004.  We  associate  this  minimal  change to the  implementation  of
production  efficiencies  and other  cost  saving  methods  offset by  increased
production  costs related to the Company's  conversion from quarterly to monthly
DVD  distribution.  Our sales and marketing costs totaled $103,539 for the three
months ending March 31, 2005,  compared to $104,451 for the same period in 2004.
Depreciation  and  amortization  costs totaled $1,227 for the three months ended
March 31, 2005.

Liquidity and Capital Resources

      As of May 10, 2005, we had cash on hand of approximately  $115,000,  which
is sufficient to satisfy our operating requirements through May 2005. To satisfy
our operating  requirements through December 2005, we estimate that we will need
an  additional  $1,200,000.  If we do not  generate  revenues  or secure debt or
equity  financing  before the end of May 2005,  we will be unable to sustain our
current level of operations and may have to cut back or shut down our operations
at that time.


                                       17
<PAGE>

      On May 16, 2002, we issued a non-interest bearing promissory note to James
Calaway,  a former director,  in the original  principal amount of $100,000 (the
"Calaway  Note").  At March 31, 2005,  the principal  balance due on the Calaway
Note was $91,500.

      In June 2002,  we issued the  following  non-interest  bearing  promissory
notes (the "Hugo/Turner  Notes"), all of which remained due and payable at March
31, 2005:

      o     Daniel V. Hugo,  a former  officer  and  director,  in the amount of
            $25,000;

      o     Robert and Janna Hugo, in the amount of $6,000; and

      o     Robert and Jamie Turner, in the amount of $5,000.

      On March 10, 2003, May 28, 2003, June 6, 2003, and July 1, 2003 we entered
into note  purchase and security  agreements  (the "Edge  Notes") with Pet Edge,
LLC, a Connecticut  limited liability  company ("Edge").  Edge was organized for
the sole  purpose  of funding  our  business  plan.  Under the terms of the Edge
Notes, Edge loaned us $1,000,000,  $50,000,  $50,000, and $275,000  respectively
with simple  interest at the rate of ten percent (10%) per annum.  All principal
and accrued  interest on the Edge Notes is due March 9, 2006, May 27, 2006, June
5, 2006,  and June 30, 2006  respectively.  The Edge Notes may not be prepaid in
whole or in part without the written  consent of Edge. To secure our obligations
under the Edge Notes, we granted Edge a first priority  security interest on all
of our assets,  now owned and  acquired  during the term of the Edge Notes.  The
principal  and  interest  on the Edge Notes is  convertible  into  shares of our
common stock, par value $.0005 ("Common Stock"), at $.246 per share. On November
10,  2003,  we  entered  into an  agreement  with  Edge to  amend  the  terms of
conversion of the Edge Notes.  Under the terms of the agreement,  the conversion
price on the Edge Notes totaling $1,375,000 provides that if shares, in segments
of not less than  $250,000,  are converted  before one year from the date of the
agreement, the conversion price will be $0.214 per share, and if converted after
one year from the date of the  agreement  and  before two years from the date of
the agreement, the conversion price will be $0.23 per share.

      Subsequently, on May 11, 2005, pursuant to the terms of a Merger Agreement
entered into by and among  African  American  Medical  Network,  Inc., a Florida
corporation,  AFMN,  Inc.,  a  Delaware  corporation,  Medical  Media,  and AAMN
Acquisition  Sub, the  principal  and interest of the  existing  Edge Notes,  as
described in the above  paragraph,  may be exchanged,  at the option of Edge for
either of (1) "Series A Zero Coupon  Preferred  Stock,"  which  preferred  stock
shall  (i)  have  a  senior  liquidation  preference  of  $1,375,000,   (ii)  be
convertible  into shares of the  Company's  Common  Stock at a fixed  conversion
price of Two and 40/100  Dollars  ($2.40) per share,  and (iii) have  preemptive
rights on an  as-converted  basis;  or (2) the number of shares of Common  Stock
issuable  pursuant  to the terms of the Edge  Notes.  If the holders of the Edge
Notes elect to convert the Edge Notes into Series A Zero Coupon Preferred Stock,
the Company shall issue to Edge three hundred  percent (300%) warrant  coverage,
calculated on the number of shares of the Company's  Common Stock  issuable upon
conversion  of the  Series  A Zero  Coupon  Preferred  Stock  (the  "Edge  Stock
Warrants").  The Edge Stock  Warrants  shall have a term of five (5) years and a
strike price of fifteen cents ($0.15).

      On  June  10,  2003,  we  entered  into  a  Note  Purchase  Agreement  and
Convertible  Promissory Note with a former director,  Mark Maltzer (the "Maltzer
Note").  Under the terms of the  Maltzer  Note,  Dr.  Maltzer  agreed to loan us
$50,000  with  simple  interest at a rate of ten  percent  (10%) per annum.  All
principal and accrued  interest is due June 9, 2006.  The principal and interest
on the Maltzer Note is convertible  into shares of our Common Stock at $.246 per
share.

      On February  13,  2004,  we entered  into a Note  Purchase  Agreement  and
Subordinated  Convertible  Promissory Note with Victus  Capital,  LP, a Delaware
limited partnership, ("Victus") ("Victus February Note"). Under the terms of the
Victus  February Note,  Victus loaned us $1,000,000 with interest of $62,500 per
quarter.  In order to insure that interest  payments were made,  $250,000 of the
principal


                                       18
<PAGE>

amount of the Victus  February Note was delivered to an escrow agent to hold for
the  purposes of making  quarterly  interest  payments  to Victus.  Prior to the
maturity date of the Victus February Note,  Victus has the option to convert the
principal  and any  outstanding  interest  into shares of a  subsequent  private
offering of  preferred  stock,  or into shares of our Common Stock at a price of
$.375 per share.  Upon  acceleration  or conversion of the Victus February Note,
any unpaid  balance in the escrow  account  would be returned to Victus.  In May
2004, we issued 357,143 shares of our Common Stock at $.70 per share and 714,286
Common  Stock  Purchase  Warrants in lieu of $250,000 in interest  due under the
Victus  February  Note.  Accordingly,  the  $250,000  being  held in escrow  was
released  to us in  exchange  for the  shares  and  warrants.  Each  warrant  is
exercisable into the Company's Common Stock at $1.00 per share. The warrants are
exercisable at any time for five years from the date of issuance. In March 2005,
Vicis Capital,  LP, a Delaware limited partnership  ("Vicis"),  acquired certain
assets of Victus. Included in the acquisition were the Victus February Note, the
357,143  shares of Common  Stock of Medical  Media,  and  714,286  Common  Stock
Purchase Warrants discussed above.

      On July 27,  2004,  the Company and Victus  entered  into a Note  Purchase
Agreement and Subordinated Convertible Promissory Note ("Victus July Note"), and
Warrant to  Purchase  Shares of Common  Stock (the  "Warrant").  Pursuant to the
terms of the Victus July Note, Victus loaned us $1,000,000, at an annual rate of
interest of twenty percent (20%) compounded semi-annually.  The Victus July Note
has a term of twelve months; however, with the consent of both parties, the term
of the Victus July Note can be extended  for an  additional  12 months.  For the
first year,  we will have the right to pay interest on the Victus July Note with
our registered,  freely  transferable Common Stock valued at a ten percent (10%)
discount  to the market.  On the date of  maturity of the Victus July Note,  the
Victus  July Note is  convertible,  at the option of Victus,  into our shares of
Common Stock at a price of $.40 per share. Pursuant to the terms of the Warrant,
Victus may  purchase up to  2,500,000  shares of our Common Stock at an exercise
price of $0.75 per share.  The Warrant expires on July 26, 2009. The Victus July
Note may not be  converted  and the Warrant may not be  exercised  to the extent
that Victus'  overall  ownership of our Common Stock will exceed  4.99%,  unless
such  limitation  is  waived by Victus  upon no less  than  sixty-one  (61) days
advance written notice.  In March 2005, Vicis acquired certain assets of Victus.
Included in the acquisition were the Victus July Note and the Warrant  discussed
above.

      On March 11, 2005, the Company issued its Series A Convertible  Debentures
("Series A Debentures") to Vicis Capital Master Series Trust  ("Vicis"),  a fund
managed by Vicis Capital,  LP, a Delaware limited  partnership,  pursuant to the
exemption from registration found in Section 4(2) of Regulation D as promulgated
by the  Securities  and Exchange  Commission  under the  Securities Act of 1933.
Pursuant to the terms of the Series A  Debentures,  Vicis  loaned the Company an
aggregate of $250,000,  at an annual rate of interest of fifteen (15%)  percent.
The Series A Debentures  have a term of 24 months and the Company has the option
to pay the interest  semi-annually in cash or in shares of its registered Common
Stock at a ten (10%)  percent  discount to the market price based on the average
five (5) days Volume  Weighted  Average  Closing Price of the  Company's  common
stock for the five (5) trading days prior to payment. On the date of maturity of
the Series A Debentures, the holder has the option to convert into shares of the
Company's Common Stock at a price of $2.40 per share (post-split).

      In addition to, and in connection  with, the  foregoing,  the Company also
issued  its  Series A Common  Stock  Purchase  Warrants,  Series B Common  Stock
Purchase Warrants, and Series C Common Stock Purchase Warrants.  Pursuant to the
terms of the Series A Common Stock Purchase  Warrants,  Vicis may purchase up to
2,500,000  shares of Common  Stock of the Company at an exercise  price of $0.10
per share for a ten-year  period.  Under the terms of the Series B Common  Stock
Purchase Warrants,  Vicis may purchase up to 2,500,000 shares of Common Stock of
the  Company at an  exercise  price of $0.11 per share for a  five-year  period.
Under  the  terms of the  Series C Common  Stock  Purchase  Warrants  Vicis  may
purchase up to  1,250,000  shares of Common  Stock of the Company at an exercise
price of $.10 per share for a one-year  period.  The Debentures and Series A, B,
and C Common Stock  Purchase  Warrants may not be converted and exercised to the
extent that Vicis'  overall  ownership  of the Common  Stock of


                                       19
<PAGE>

the Company will exceed 4.99%, unless such limitation is waived by Vicis upon no
less than sixty-one (61) days advance written notice.

      Pursuant  to the  terms  of the  Merger  Agreement  discussed  above,  the
principal  and interest of the Victus  February  Note,  Victus July Note and the
Debentures,  in the aggregate of  $2,250,000,  and the principal and interest of
the existing Maltzer Note for $50,000 (the "Convertible Debt") may be exchanged,
at the option of Victus or Maltzer (the "Convertible Debt Holders"),  for either
of (1) "Series B Zero Coupon  Preferred  Stock," which  preferred  stock,  after
giving  effect  to  the  Series  A  Zero  Coupon  Preferred  Stock   liquidation
preference,  shall have a  liquidation  preference of  $2,300,000,  and shall be
convertible  into shares of the  Company's  Common  Stock at a fixed  conversion
price of Three  Dollars  ($3.00)  per share;  or (2) the number of shares of the
Company's Common Stock issuable  pursuant to the terms of the Convertible  Debt.
If the  Convertible  Debt  Holders  elect to convert the  Convertible  Debt into
Series B Zero Coupon Preferred Stock, the Company shall issue to the Convertible
Debt Holders two hundred twenty five percent (225%) warrant coverage, calculated
on the number of shares of Medical Media's Common Stock issuable upon conversion
of the  Series B Zero  Coupon  Preferred  Stock  (the  "Convertible  Note  Stock
Warrants").  The  Convertible  Note Stock Warrants shall have a term of five (5)
years and a strike price of fifteen cents ($0.15).

      From  inception  through March 31, 2005, we incurred  interest  expense of
approximately   $672,000.   This  amount  includes  accrued  interest   totaling
approximately  $417,000  related to the Edge Notes, the Maltzer Note, the Victus
July Note and the Vicis Note; $250,000 payment of interest related to the Victus
February Note (in May 2004, we issued 357,143 shares of our Common Stock at $.70
per share and  714,286  Common  Stock  purchase  warrants in lieu of $250,000 in
interest due), and approximately $5,000 in interest paid.

      If we do not generate revenues or secure debt or equity financing, we will
be unable to pay one or more of the obligations referenced above.

Forward-Looking Statements. Information included or incorporated by reference in
this Form 10-QSB may contain  forward-looking  statements,  which we believe are
within the meaning of the  Securities  Exchange  Act of 1934,  as amended.  This
information may involve known and unknown risks, uncertainties and other factors
which may cause our actual results, performance or achievements to be materially
different  from the future  results,  performance or  achievements  expressed or
implied by any forward-looking  statements.  Forward-looking  statements,  which
involve assumptions and describe our future plans,  strategies and expectations,
are  generally  identifiable  by use  of  the  words  "may,"  "will,"  "should,"
"expect,"  "anticipate,"  "estimate,"  "believe,"  "intend" or "project," or the
negative  of these  words  or other  variations  on  these  words or  comparable
terminology.

Item 3.    Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

      As of the end of the period  covered by this report,  the Company  carried
out an  evaluation,  under the  supervision  and with the  participation  of the
Company's  Principal  Executive  Officer and Principal  Financial Officer of the
effectiveness of the design and operation of the Company's  disclosure  controls
and procedures. The Company's disclosure controls and procedures are designed to
ensure that information required to be disclosed by us in the reports we file or
submit under the Exchange Act is recorded,  processed,  summarized and reported,
within the time periods  specified in the Securities  and Exchange  Commission's
rules and  forms.  The  Company's  Principal  Executive  Officer  and  Principal
Financial  Officer have  concluded  that the Company's  disclosure  controls and
procedures are, in fact,  effective at this reasonable assurance level as of the
period covered.


                                       20
<PAGE>

Changes in Internal Controls Over Financial Reporting

      In  connection  with the  evaluation of the  Company's  internal  controls
during the  Company's  quarter  ended March 31, 2005,  the  Company's  Principal
Executive Officer and Principal Financial Officer have determined that there are
no changes to the Company's internal controls over financial reporting that have
materially  affected,  or  are  reasonably  likely  to  materially  effect,  the
Company's internal controls over financial reporting.

PART II - OTHER INFORMATION

Item 1.    Legal Proceedings.

None.

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3.    Defaults upon Senior Securities.

None.

Item 4.    Submission of Matters to a Vote of Security Holders.

      A  Written  Action of a  Majority  of the  Shareholders  in Lieu of Annual
Meeting  was  signed on March 18,  2005 in which  6,964,028  shares of the total
shares of Common Stock outstanding of 13,091,685  (53.19%) approved the election
of the following directors:  Philip M. Cohen,  Chairman of the Board, Jeffrey I.
Werber,  Bernard Kouma, John Sfondrini,  J. Holt Smith,  Michael Marcovsky,  and
Stanley Raphael.  The shareholders also confirmed Baumann,  Raymondo & Co., P.A.
as the Company's  accountants  and auditing  firm, and approved the filing of an
Amendment to the Articles of Incorporation to increase the authorized  shares of
Common  Stock  from  50,000,000  to  100,000,000  with a par value of $.0005 per
share, and to increase the authorized  shares of Preferred Stock from 10,000,000
to 25,000,000, with a par value of zero.

Item 5.    Other Information.

Subsequent Events

      A Written  Action of a  Majority  of the  Shareholders  in Lieu of Special
Meeting  was signed on April 6,  2005,  in which  7,079,471  shares of the total
shares  of  Common  Stock  outstanding  of  13,091,685   (54.07%)  approved  the
Memorandum of Terms for the Company's  acquisition of African  American  Medical
Network,  Inc., a  wholly-owned  subsidiary  of AFMN,  Inc. and  authorized  the
Company's  Board of Directors to (i) change the  Company's  corporate  name from
PetCARE Television Network, Inc. to Medical Media Television, Inc.; (ii) combine
the Company's issued and outstanding Common Stock on a 1:30 basis,  effective as
of May 4, 2005;  and (iii) declare and issue a dividend of two (2) shares of the


                                       21
<PAGE>

Company's  restricted  common  stock  for each  share of  common  stock  held by
shareholders of record as of May 10, 2005.

      On May 6, 2005,  the Company  issued its Series B  Convertible  Debentures
("Series B Debentures") to Vicis Capital Master Series Trust  ("Vicis"),  a fund
managed by Vicis Capital,  LP, a Delaware limited  partnership,  pursuant to the
exemption from registration found in Section 4(2) of Regulation D as promulgated
by the  Securities  and Exchange  Commission  under the  Securities Act of 1933.
Pursuant to the terms of the Series B  Debentures,  Vicis  loaned the Company an
aggregate of $250,000,  at an annual rate of interest of fifteen (15%)  percent.
The Series B Debentures  have a term of 24 months and the Company has the option
to pay the interest  semi-annually in cash or in shares of its registered Common
Stock at a ten percent  (10%)  discount to the market price based on the average
five (5) days Volume  Weighted  Average  Closing Price of the  Company's  Common
Stock for the five (5) trading days prior to payment. On the date of maturity of
the Series B Debentures, the holder has the option to convert into shares of the
Company's Common Stock at a price of $2.40 per share (post-split).

      In addition to, and in connection  with, the  foregoing,  the Company also
issued  its  Series D Common  Stock  Purchase  Warrants,  Series E Common  Stock
Purchase  Warrants,  and  Series F Common  Stock  Purchase  Warrants  to  Vicis.
Pursuant to the terms of the Series D Common Stock Purchase Warrants,  Vicis may
purchase up to 104,167 shares of the Company's Common Stock at an exercise price
of $2.40 per share for a ten (10) year  period.  Under the terms of the Series E
Common Stock Purchase  Warrants,  Vicis may purchase up to 104,167 shares of the
Company's  Common  Stock at an exercise  price of $2.40 per share for a five (5)
year  period.  Under the terms of the Series F Common Stock  Purchase  Warrants,
Vicis may  purchase up to 104,167  shares of the  Company's  Common  Stock at an
exercise price of $2.40 per share for a one-year period. The Series B Debentures
and Series D, E, and F Common Stock  Purchase  Warrants may not be converted and
exercised to the extent that Vicis' overall ownership of the Common Stock of the
Company giving effect to that  conversion and together with the right to receive
any common stock within sixty (60) days of the conversion date will exceed 4.99%
of the Company's outstanding stock at that time.

      On May 11, 2005 the Company  executed that certain  Merger  Agreement (the
"Merger  Agreement") by and among AFMN,  Inc. a Delaware  corporation  ("AFMN"),
African American Medical Network,  Inc. a Florida corporation ("African American
Medical"),  and AAMN  Acquisition  Sub, whereby the Company will acquire 100% of
the capital stock of African American Medical in exchange for 14,865,657  shares
of its common stock. African American Medical provides  educational  programming
to patients through  installation of viewing systems in doctor's offices serving
the African-American  population.  Pursuant to the terms of the Agreement,  AAMN
Acquisition Sub will be merged with and into African American Medical,  and AFMN
will receive the  aforementioned  shares of Medical Media in exchange for all of
AFMN's shares of the capital stock of African American Medical.  Pursuant to the
terms of the  Merger  Agreement,  the  Company  intends  to file a  Registration
Statement on Form S-4 with the  Securities and Exchange  Commission  (the "SEC")
registering  the shares the Company  intends to issue  AFMN.  The closing of the
Merger  Agreement  will occur within  three (3)  business  days of the date upon
which the registration  statement on Form S-4 is declared  effective by the SEC,
which  will be filed as soon as  practical.  A copy of the Merger  Agreement  is
being filed herewith as Exhibit 10.2.


                                       22
<PAGE>

Item 6.    Exhibits.

3.1        Amended and Restated Articles of  Incorporation,  previously filed as
           an Exhibit to the Company's Registration Statement on Form SB-2 filed
           with  the  Commission  on  June  4,  2003,  as  amended,  are  hereby
           incorporated herein by reference.

3.2        Articles of Amendment to the  Articles of  Incorporation,  previously
           filed as an Exhibit to the Company's  Registration  Statement on Form
           SB-2  filed with the  Commission  on June 4, 2003,  as  amended,  are
           hereby incorporated herein by reference.

3.3        Articles of Amendment to the  Articles of  Incorporation,  previously
           filed as an Exhibit to the Company's  Registration  Statement on Form
           SB-2  filed with the  Commission  on June 4, 2003,  as  amended,  are
           hereby incorporated herein by reference.

3.4        Articles of Amendment to the  Articles of  Incorporation,  previously
           filed as an Exhibit to the Company's  Quarterly Report on Form 10-QSB
           filed with the Commission on August 18, 2004, are hereby incorporated
           herein by reference.

3.5        Articles of Amendment to the  Articles of  Incorporation,  previously
           filed as an Exhibit to the  Company's  Annual  Report on Form  10-KSB
           filed with the Commission on March 31, 2005, are hereby  incorporated
           herein by reference.

*3.6       Articles of Amendment to the Articles of Incorporation filed on April
           21, 2005.

3.7        Bylaws of PetCARE  Television  Network,  Inc.  previously filed as an
           Exhibit to the  Company's  Registration  Statement on Form SB-2 filed
           with  the  Commission  on  June  4,  2003,  as  amended,  are  hereby
           incorporated herein by reference.

*10.1      Series A Convertible  Debenture to Vicis Capital  Master Series Trust
           dated March 16, 2005.

*10.2      Series A Common Stock Purchase Warrant to Vicis Capital Master Series
           Trust dated March 16, 2005.

*10.3      Series B Common Stock Purchase Warrant to Vicis Capital Master Series
           Trust dated March 16, 2005.

*10.4      Series C Common Stock Purchase Warrant to Vicis Capital Master Series
           Trust dated March 16, 2005.

*10.5      Merger Agreement by and among African American Medical Network, Inc.,
           AFMN,  Inc., AAMN Acquisition Sub, Inc. and the Company dated May 11,
           2005.

*31.1      Written  Statement of Chief Executive Officer pursuant to Section 302
           of the Sarbanes-Oxley Act of 2002.

*31.2      Written  Statement of Chief Financial Officer pursuant to Section 302
           of the Sarbanes-Oxley Act of 2002.

*32.1      Written  Statement of Chief Executive Officer pursuant to Section 906
           of the Sarbanes-Oxley Act of 2002.

*32.2      Written  Statement of Chief Financial Officer pursuant to Section 906
           of the Sarbanes-Oxley Act of 2002.

* Filed herewith.


                                       23
<PAGE>

                                   SIGNATURES

      In accordance  with the  requirements  of the Exchange Act, the Registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

Dated: May 16, 2005                     MEDICAL MEDIA TELEVISION, INC.


                                        By: /s/ Philip M. Cohen
                                            ------------------------------------
                                            Philip M. Cohen, President and Chief
                                            Executive Officer


                                        By: /s/ Donald R. Mastropietro
                                            ------------------------------------
                                            Donald R. Mastropietro,  Vice
                                            President Finance and Chief
                                            Financial Officer


                                       24